Sign in
4

Changes in Ownership

Larimar Therapeutics, Inc. Filed Acc 0001062993-24-011568

Director bought 57,208 shares at $8.74 ($499,998)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Hamilton Thomas Edward Director 2024-02-16 Purchase +57,208 $8.74 $499,998 564,798 D: show line 1 in the form
Open-market purchases · 57,208 sh · avg $8.74 · $499,998

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Hamilton Thomas Edward Director 2024-05-29 Grant or award · Stock Option (Right to Buy) +19,000 19,000 D: show line 2 in the form
Loading xslF345X05/form4.xml…